Taken together, these results indicate that i.t. injected SLR14 is mainly taken up by CD11b+ tumor-infiltrating myeloid cells, and some SLR14+CD11b+ cells can be found in the dLN 1 d after the treatment. Here, ITGAM is linked to neoplasm.